Patent Assignment
Reel/Frame 020024/0545
Assignment of Assignor's Interest
Recorded: 2007-10-29
Received: 2007-10-29
Pages: 10
Assignor
ARYX THERAPEUTICS
Executed: 2007-10-22
Assignee
ARYX THERAPEUTICS, INC.
6300 DUMBARTON CIRCLE, FREMONT, CA, 94555, UNITED STATES
Covered Properties
(30)
Materials And Methods For Treating Coagulation Disorders
Application:
11/551,302 →
Synthetic Methods and Intermediates for Stereoisomeric Compounds Useful for the Treatment of Gastrointestinal and Central Nervous System Disorders
Application:
11/469,264 →
Antiarrhythmic Precursor Compounds, Methods of Synthesis and Methods of Use
Application:
11/457,719 →
Materials and Methods for Treating Hypercholesterolemia
Application:
11/220,364 →
Materials and Methods for Treating Coagulation Disorders
Application:
11/101,714 →
Novel Compounds for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Application:
11/074,152 →
Materials and Methods for the Treatment of Depression
Application:
10/931,586 →
Novel 5-HT3 Receptor Antagonists and Methods of Use
Application:
10/857,108 →
Materials and Methods for Treating Coagulation Disorders
Application:
10/822,129 →
Novel Compounds for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Application:
10/799,546 →
Ultrashort-Acting Opioids for Transdermal Applications
Application:
10/771,483 →
Ultrashort Acting Hypnotic Barbiturates
Application:
10/763,904 →
Materials and Methods for the Treatment of Diabetes, Hyperlipidemia, Hypercholesterolemia, and Atherosclerosis
Application:
10/759,617 →
Novel Enantiomeric Compounds for Treatment of Cardiac Arrhythmias and Methods of Use
Application:
10/697,683 →
Materials and Methods for the Treatment of Hypertension and Angina
Application:
10/643,699 →
Novel 5-HT3 Receptor Antagonists and Methods of Use
Application:
10/348,669 →
Novel Compounds for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Application:
10/319,073 →
Materials and Methods for the Treatment of Depression
Application:
10/273,702 →
Materials and Methods for the Treatment of Hypertension and Angina
Application:
10/269,139 →
Materials and Methods for the Treatment of Diabetes, Hyperlipidemia, Hypercholesterolemia, and Atherosclerosis
Application:
10/251,522 →
Ultrashort Acting Hypnotic Barbiturates
Application:
10/145,601 →
Materials and Methods for Treating Coagulation Disorders
Application:
10/132,750 →
Novel Enantiomeric Compounds for Treatment of Cardiac Arrhythmias and Methods of Use
Application:
10/123,573 →
Ultrashort-Acting Opioids for Transdermal Application
Application:
10/116,320 →
Materials and Methods for the Treatment of Diabetes, Hyperlipidemia, Hypercholesterolemia, and Atherosclerosis
Application:
09/961,542 →
Isoxazolidine Compounds Useful in the Treatment of Diabetes, Hyperlipidemia, and Atherosclerosis in Mammals
Application:
09/961,538 →
Materials and Methods for the Treatment of Gastroesophageal Reflux Disease
Application:
09/876,698 →
Materials and Methods for the Treatment of Depression
Application:
09/841,749 →
Materials and Methods for the Treatment of Diabetes, Hyperlipidemia, Hypercholesterolemia, and Atherosclerosis
Application:
09/841,351 →
Ultrashort Acting Hypnotic Barbiturates
Application:
09/841,738 →